Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)

HKD 1.3

(-2.99%)

Long Term Debt Summary of Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd.'s latest annual long term debt in 2023 was 121.96 Million CNY , down -9.43% from previous year.
Jacobio Pharmaceuticals Group Co., Ltd.'s latest quarterly long term debt in 2024 Q1 was - CNY , down 0.0% from previous quarter.
Jacobio Pharmaceuticals Group Co., Ltd. reported annual long term debt of 134.66 Million CNY in 2022, up 7028.8% from previous year.
Jacobio Pharmaceuticals Group Co., Ltd. reported annual long term debt of 1.88 Million CNY in 2021, down -6.07% from previous year.
Jacobio Pharmaceuticals Group Co., Ltd. reported quarterly long term debt of - CNY for 2024 Q2, down 0.0% from previous quarter.
Jacobio Pharmaceuticals Group Co., Ltd. reported quarterly long term debt of 128 Million CNY for 2023 Q1, down -4.95% from previous quarter.

Annual Long Term Debt Chart of Jacobio Pharmaceuticals Group Co., Ltd. (2023 - 2018)

Historical Annual Long Term Debt of Jacobio Pharmaceuticals Group Co., Ltd. (2023 - 2018)

Year	Long Term Debt	Long Term Debt Growth
2023	121.96 Million CNY	-9.43%
2022	134.66 Million CNY	7028.8%
2021	1.88 Million CNY	-6.07%
2020	2.01 Million CNY	-81.39%
2019	10.8 Million CNY	-30.13%
2018	15.46 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- CNY	0.0%
2024 Q2	- CNY	0.0%
2023 Q1	128 Million CNY	-4.95%
2023 FY	121.96 Million CNY	-9.43%
2023 Q4	121.96 Million CNY	0.0%
2023 Q3	121.96 Million CNY	-4.71%
2023 Q2	128 Million CNY	0.0%
2022 Q3	134.66 Million CNY	25023.69%
2022 Q2	536 Thousand CNY	0.0%
2022 Q1	536 Thousand CNY	-71.63%
2022 FY	134.66 Million CNY	7028.8%
2022 Q4	134.66 Million CNY	0.0%
2021 Q3	1.88 Million CNY	-26.87%
2021 Q4	1.88 Million CNY	0.0%
2021 Q1	2.58 Million CNY	28.44%
2021 FY	1.88 Million CNY	-6.07%
2021 Q2	2.58 Million CNY	0.0%
2020 FY	2.01 Million CNY	-81.39%
2020 Q4	2.01 Million CNY	0.0%
2020 Q3	2.01 Million CNY	-80.96%
2020 Q2	10.56 Million CNY	0.0%
2020 Q1	10.56 Million CNY	-2.28%
2019 FY	10.8 Million CNY	-30.13%
2019 Q1	- CNY	0.0%
2019 Q3	10.8 Million CNY	0.0%
2019 Q4	10.8 Million CNY	0.0%
2018 FY	15.46 Million CNY	0.0%

Peer Long Term Debt Comparison of Jacobio Pharmaceuticals Group Co., Ltd.

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-298.435%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	97.146%